ArticleMolecular medicine (Cambridge, Mass.)2023

Therapeutic effects of engineered exosome-based miR-25 and miR-181a treatment in spinocerebellar ataxia type 3 mice by silencing ATXN3.

Zhenchu Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.